Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis

Published:2014-07-24 Issue:2 Volume:94 Page:152-156
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Pettersson Helna¹,Knutsen Håvar²,Holmberg Erik³,Andréasson Björn¹⁴

Affiliation:

1. Hematology section; Uddevalla, NU hospital group; Uddevalla Sweden

2. Hematology section; Ullevål Hospital; Oslo Norway

3. Regional Oncology Center; Göteborg Sweden

4. Section of Hematology and Coagulation; Sahlgrenska University Hospital; Göteborg Sweden

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12410/fullpdf

Reference19 articles.

1. Myeloproliferative neoplasms and thrombosis;Barbui;Blood,2013

2. Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management;Casini;J Thromb Haemost,2013

3. Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders;Cervantes;Leukemia,2008

4. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms;Björkholm;J Clin Oncol,2011

5. Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study;Frederiksen;Blood,2011

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review;Current Issues in Molecular Biology;2024-08-02

2. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan;Hematology;2024-04-16

3. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms;Cancers;2023-08-29

4. Risk of second primary malignancy in patients with primary myelofibrosis: a SEER database study;Leukemia & Lymphoma;2022-09-18

5. Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide;eJHaem;2022-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3